FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 141 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,247,000 | +242.1% | 513,629 | +18.1% | 0.01% | +200.0% |
| Q2 2022 | $2,995,000 | +49.7% | 434,744 | +102.1% | 0.00% | +100.0% |
| Q1 2022 | $2,001,000 | +171.9% | 215,141 | +315.5% | 0.00% | – |
| Q4 2021 | $736,000 | -67.1% | 51,776 | -46.3% | 0.00% | -100.0% |
| Q3 2021 | $2,236,000 | -7.0% | 96,425 | -0.2% | 0.00% | 0.0% |
| Q2 2021 | $2,404,000 | -42.8% | 96,586 | -35.7% | 0.00% | -50.0% |
| Q1 2021 | $4,206,000 | -39.8% | 150,140 | -25.1% | 0.00% | -60.0% |
| Q4 2020 | $6,991,000 | -52.3% | 200,328 | -36.4% | 0.01% | -75.0% |
| Q2 2020 | $14,645,000 | – | 315,006 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EDBI Pte Ltd | 1,268,805 | $8,742,000 | 8.10% |
| Samsara BioCapital, LLC | 1,565,526 | $10,786,000 | 2.88% |
| Deep Track Capital, LP | 4,050,000 | $27,905,000 | 1.83% |
| RA Capital Management | 9,011,651 | $62,090,000 | 1.66% |
| Cormorant Asset Management, LP | 3,172,204 | $21,856,000 | 1.65% |
| ARMISTICE CAPITAL, LLC | 4,736,000 | $32,631,000 | 0.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 94,386 | $650,000 | 0.20% |
| Parkman Healthcare Partners LLC | 78,603 | $542,000 | 0.20% |
| Integral Health Asset Management, LLC | 130,051 | $896,000 | 0.18% |
| Opaleye Management Inc. | 58,700 | $404,000 | 0.18% |